“…Both structural information 1 Abbreviations: DAG, sn-1,2-diacylglycerol; DHPC, diaheptanoylsn-glycero-3-phosphocholine; DPPsI, 1,2-dipalmitoyl-sn-glycero-3-(1-thiophospho-1D-myo-inositol); EDTA, ethylenediaminetetraacetic acid; HEPES, N-(2-hydroxyethyl) piperazine-N′-(2-ethanesulfonic acid); HSQC, heteronuclear single quantum coherence; [ 3 H]-PI, L-R-[myoinositol-2-3 H(N)]-phosphatidylinositol; IP, inositol 1-phosphate; IcP, inositol 1,2-cyclic phosphate; NMR, nuclear magnetic resonance; NOESY, nuclear Overhauser enhancement spectroscopy; PI, phosphatidylinositol; PI-PLC, phosphatidylinositol-specific phospholipase C; Tris, tris (hydroxyethyl) aminomethane; WT, wild type. and the results from stereochemical and mutagenesis studies have indicated that these two similarly positioned positively charged moieties play similar catalytic roles: both stabilize the transition state of the phosphoryl transfer reaction via interaction with pro-S oxygen of the phosphodiester moiety and facilitate deprotonation of the 2-OH of the inositol ring (16,18,(27)(28)(29). However, it is not clear whether, and how, the use of Ca 2+ versus Arg could be responsible for the differences in the substrate specificity and the product profile (ratio of the cyclic to acyclic product) between mammalian and bacterial enzymes.…”